Otto Ettala

University of Turku, Turku University Hospital

Papers

4

Total Citations

19

H-Index

3

About

Otto Ettala is a leading researcher in urological oncology, whose work centers on improving the detection, staging, and management of prostate cancer. His most impactful contributions bridge advanced imaging and surgical outcomes. Ettala’s landmark prospective study on 18F-PSMA-1007 PET/CT and whole-body MRI established a new benchmark for intraprostatic tumor detection and T-staging in high-risk prostate cancer, directly correlating PSMA uptake with immunohistochemical expression. This work, alongside his critical evaluation of hormone-naïve primary prostate cancer xenografts, has advanced both clinical diagnostics and preclinical modeling. Ettala also investigates perioperative care, demonstrating how multimodal anesthesia with pre-emptive pregabalin can reduce opioid requirements after robot-assisted laparoscopic prostatectomy. Furthermore, his large-cohort study on ultrasensitive PSA after radical prostatectomy provides crucial insights for predicting biochemical recurrence. With over 19 citations across his most-cited papers, Ettala’s research is shaping evidence-based practice in prostate cancer imaging, surgical recovery, and disease monitoring.

Research Focus

Key Achievements

3
H-Index
4
Papers
19
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: University of Turku, Turku University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago